Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on August 7, 2025
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and …
Strategic News: Digital Pathology Market to Hit $2.75B by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The global digital pathology market, valued at US$1.30 billion in 2024 stood at US$1.46 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a …
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork …
Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update
- Positive 6 Month Clinical Data Reported for Ongoing Pediatric Netherton Syndrome Study - FDA Clears Second Pivotal Study of QRX003 for Netherton Syndrome - Initial Positive Data Announced from Peeling Skin Syndrome Pediatric Study - Orphan Drug …
Gain a competitive career edge with CompTIA Project Management Essentials
DOWNERS GROVE, Ill., Aug. 07, 2025 (GLOBE NEWSWIRE) -- A new option to learn the fundamentals of project management and enhance your employability profile is available from CompTIA, the leading global provider of vendor-neutral information technology (IT) …
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
- Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company …
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through system upgrades …
NetworkNewsAudio Announces Audio Press Release (APR) on Expanding Neural Tech Leadership in Booming AI Wearables Market
AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Neural Tech Drives the Growth of the AI Wearables Market,” featuring Wearable Devices Ltd. (NASDAQ: WLDS). To hear the …
ZenaTech Acquires Cardinal Civil Resources, a Virginia-Based Land Surveying and Engineering Firm Serving Three States and Large Customers Including US Department of Transportation
VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI-powered drones, Drone as a Service (DaaS), Enterprise SaaS, and …
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a …
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
Company on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) under accelerated approval pathway in October 2025, supported by successful pre-NDA meeting Expect initial data from Phase 2 study of DISC-0974 in patients with anemia of …
Alarum to Participate at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025
Presentation scheduled for Wednesday, August 13, 2025, at 8:30 a.m. ET Tel Aviv, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR), a global provider of web data collection solutions, announced that its Chief …
Roadzen Onboards UK’s Leading Automotive Finance Broker, Motion Finance, to Deliver Embedded GAP Insurance for Vehicle Finance Customers
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the intersection of insurance and mobility, today announced that its wholly owned UK-based subsidiary, Global Insurance …
Champion Safe Co. Reports 30% Sales Growth with Northwest Safe — The Northwest’s Premier Retailer and a National Voice in Safe Security
American Rebel Holdings, Inc. (NASDAQ: AREB) and Champion Safe Co. are committed to doing great business with top-tier partners who share our American values and proudly stand behind them — like Northwest Safe, a respected authority and unapologetic voice …
Geotab celebra su 25º aniversario: impulsando el futuro de los vehículos conectados
MADRID, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Geotab celebra hoy su 25º aniversario, marcando un hito por su crecimiento global, su capacidad pionera en innovación basada en inteligencia artificial y su compromiso constante con clientes, partners y empleados. …
Safe Pro Group Advances its AI Patent Protection Internationally, Receiving Publication Notifications in Australia, Israel, and European Region
AVENTURA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a leader in artificial intelligence (AI)-powered defense and security solutions today announced the continued expansion of the …
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025
FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …
Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Full Alliance Group's Quant Blockchain Developing HIPAA-Compliant Healthcare Data Sharing Solution
TAMPA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its Qubitera Holdings subsidiary is developing breakthrough technology that will help hospitals and healthcare systems share patient information …